Berlin — Dec Group, a port­fo­lio company of capi­ton V Fund and the world’s leading supplier of contain­ment powder hand­ling systems, has acqui­red the Extract Tech­no­logy busi­ness unit from US-listed Wabash Natio­nal Corpo­ra­tion, a company listed on the New York Stock Exch­ange. BMH BRÄUTIGAM advi­sed the DEC Group on the finan­cing of the acqui­si­tion of Extract Tech­no­logy (UK / US).

Extract Tech­no­logy is a leading provi­der of contain­ment and asep­tic systems for the phar­maceu­ti­cal, biotech, nuclear and chemi­cal markets. Extract is head­quar­te­red in Hudders­field, UK, with an addi­tio­nal site in New Lisbon, USA, serving the fast-growing US market.

Advi­sor DEC Group: BMH BRÄUTIGAM in rela­tion to the finan­cing and acqui­si­tion of further shares in group companies.
Dr. Andrea Reichert-Clauß, David Thüning, Tina Schmidt, Till Wans­le­ben (all Private Equity ǀ Corporate/M&A)

For aspects of Swiss law, BMH BRÄUTIGAM consul­ted MLL Meyer­lus­ten­ber­ger Lache­nal (lead Dr. Chris­toph Heiz) from its inter­na­tio­nal network.
The BMH BRÄUTIGAM team has been advi­sing capi­ton for years, inclu­ding on the acqui­si­tion of the DEC Group.

Other advi­sors to DEC:

xtSho­os­miths (Legal UK / Tran­sac­tion, led by Simon Proc­ter), PwC (Finan­cial), EY (Tax).

Advi­sors to banks: Baker McKen­zie (lead Dr. Philip Spoerlé, Zurich).